How Castor Oil Stimulates Labor

Researchers flag the EP3 prostaglandin receptor as a key player in castor oil’s laxative and labor-inducing effects.

By | May 21, 2012

WIKIMEDIA COMMONS, PETE MARKHAM

People have long taken castor oil to help ease constipation and induce labor, but until now, little was known about how the pressed oil of the castor bean actually works. Now, scientists have found that ricinoleic acid, a key component of castor oil, targets prostaglandin receptors on smooth muscle cells in the intestines and uterus to stimulate contractions, according to research published today (May 21) in Proceedings of the National Academy of Sciences.

Researchers in Germany identified EP3, a receptor for prostaglandin E2, a hormone-like molecule that mediates a range of functions, including labor and temperature control, after screening human cell lines for responses to ricinoleic acid. Although ricinoleic acid administered to normal mice produced diarrhea, mice lacking EP3 showed no ill effects from ricinoleic acid ingestion. Ricinoleic acid also stimulated uterine contractions in pregnant wild type uterine tissue, but not in uteri from EP3-deficient mice.

Castor oil’s specific mechanism of action is “unexpected because castor oil has been regarded as an agent that exerts its effects through unspecific mechanisms,” the authors noted, but the data identify EP3 receptors as “potential targets for drugs to induce laxation.”

Read more about the science behind different alternative medicines, including probiotics, acupuncture, and medical marijuana, in The Scientist’s July issue.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. What Budget Cuts Might Mean for US Science
    News Analysis What Budget Cuts Might Mean for US Science

    A look at the historical effects of downsized research funding suggests that the Trump administration’s proposed budget could hit early-career scientists the hardest.  

  2. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  3. Opinion: On “The Impact Factor Fallacy”
  4. Unstructured Proteins Help Tardigrades Survive Desiccation
Business Birmingham